IRIS Accounts Production v25.1.0.734 11458825 director 1.8.23 31.7.24 31.7.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh114588252023-07-31114588252024-07-31114588252023-08-012024-07-31114588252022-07-31114588252022-08-012023-07-31114588252023-07-3111458825ns15:EnglandWales2023-08-012024-07-3111458825ns14:PoundSterling2023-08-012024-07-3111458825ns10:Director12023-08-012024-07-3111458825ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3111458825ns10:SmallEntities2023-08-012024-07-3111458825ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3111458825ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3111458825ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3111458825ns10:FullAccounts2023-08-012024-07-3111458825ns10:OrdinaryShareClass12023-08-012024-07-3111458825ns10:RegisteredOffice2023-08-012024-07-3111458825ns5:CurrentFinancialInstruments2024-07-3111458825ns5:CurrentFinancialInstruments2023-07-3111458825ns5:Non-currentFinancialInstruments2024-07-3111458825ns5:Non-currentFinancialInstruments2023-07-3111458825ns5:ShareCapital2024-07-3111458825ns5:ShareCapital2023-07-3111458825ns5:RetainedEarningsAccumulatedLosses2024-07-3111458825ns5:RetainedEarningsAccumulatedLosses2023-07-3111458825ns5:ComputerEquipment2023-08-012024-07-3111458825ns5:ComputerEquipment2023-07-3111458825ns5:ComputerEquipment2024-07-3111458825ns5:ComputerEquipment2023-07-3111458825ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3111458825ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3111458825ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-07-3111458825ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-07-3111458825ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-07-3111458825ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-07-3111458825ns5:AcceleratedTaxDepreciationDeferredTax2024-07-3111458825ns5:AcceleratedTaxDepreciationDeferredTax2023-07-3111458825ns5:DeferredTaxation2023-07-3111458825ns5:DeferredTaxation2023-08-012024-07-3111458825ns5:DeferredTaxation2024-07-3111458825ns10:OrdinaryShareClass12024-07-31114588251ns10:Director12023-07-31114588251ns10:Director12022-07-31114588251ns10:Director12023-08-012024-07-31114588251ns10:Director12022-08-012023-07-31114588251ns10:Director12024-07-31114588251ns10:Director12023-07-31
REGISTERED NUMBER: 11458825 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024

FOR

NEW MODEL MEDICINE LTD

NEW MODEL MEDICINE LTD (REGISTERED NUMBER: 11458825)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


NEW MODEL MEDICINE LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2024







DIRECTOR: Dr R M Lascar





REGISTERED OFFICE: 55 Loudoun Road
London
NW8 0DL





REGISTERED NUMBER: 11458825 (England and Wales)





ACCOUNTANTS: MGR SD Limited
Chartered Accountants
55 Loudoun Road
London
NW8 0DL

NEW MODEL MEDICINE LTD (REGISTERED NUMBER: 11458825)

BALANCE SHEET
31 JULY 2024

31.7.24 31.7.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 716 954

CURRENT ASSETS
Debtors 5 47,096 28,547
Cash at bank 3,378 5,671
50,474 34,218
CREDITORS
Amounts falling due within one year 6 (33,193 ) (34,552 )
NET CURRENT ASSETS/(LIABILITIES) 17,281 (334 )
TOTAL ASSETS LESS CURRENT LIABILITIES 17,997 620

CREDITORS
Amounts falling due after more than one
year

7

(17,500

)

-

PROVISIONS FOR LIABILITIES 9 (136 ) (181 )
NET ASSETS 361 439

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 261 339
SHAREHOLDERS' FUNDS 361 439

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NEW MODEL MEDICINE LTD (REGISTERED NUMBER: 11458825)

BALANCE SHEET - continued
31 JULY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 16 April 2025 and were signed by:





Dr R M Lascar - Director


NEW MODEL MEDICINE LTD (REGISTERED NUMBER: 11458825)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024


1. STATUTORY INFORMATION

New Model Medicine Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on reducing balance

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 August 2023
and 31 July 2024 2,209
DEPRECIATION
At 1 August 2023 1,255
Charge for year 238
At 31 July 2024 1,493
NET BOOK VALUE
At 31 July 2024 716
At 31 July 2023 954

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Other debtors 47,096 28,547

NEW MODEL MEDICINE LTD (REGISTERED NUMBER: 11458825)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Bank loans and overdrafts (see note 8) 10,000 -
Taxation and social security 20,393 31,080
Other creditors 2,800 3,472
33,193 34,552

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.7.24 31.7.23
£    £   
Bank loans (see note 8) 17,500 -

8. LOANS

An analysis of the maturity of loans is given below:

31.7.24 31.7.23
£    £   
Amounts falling due within one year or on demand:
Bank loans 10,000 -

Amounts falling due between one and two years:
Bank loans - 1-2 years 10,000 -

Amounts falling due between two and five years:
Bank loans - 2-5 years 7,500 -

9. PROVISIONS FOR LIABILITIES
31.7.24 31.7.23
£    £   
Deferred tax
Accelerated capital allowances 136 181

Deferred
tax
£   
Balance at 1 August 2023 181
Provided during year (45 )
Balance at 31 July 2024 136

NEW MODEL MEDICINE LTD (REGISTERED NUMBER: 11458825)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024


10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
100 Ordinary £1 100 100

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 July 2024 and 31 July 2023:

31.7.24 31.7.23
£    £   
Dr R M Lascar
Balance outstanding at start of year 28,547 13,804
Amounts advanced 152,728 88,043
Amounts repaid (134,179 ) (73,300 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 47,096 28,547